Epithalon
Research useSynthetic peptide (4 amino acids)
Last updated 29 October 2026
Epithalon is a synthetic peptide of four amino acids, developed in Russia from a substance found in the pineal gland. It is studied for ageing, with a well known claim that it can switch on the enzyme that maintains the ends of chromosomes. The evidence is laboratory and animal work, and it is not a licensed medicine in the UK.
Key points
- Epithalon (also spelled Epitalon) is a four amino acid peptide, a synthetic version of a pineal gland substance.
- It is best known for a claim that it activates telomerase, the enzyme that rebuilds the protective caps on chromosomes.
- That claim rests on a cell study and on animal work, not on human trials.
- It is not a licensed medicine in the UK and is sold only for research use.
Quick facts
- What it is
- Synthetic peptide, 4 amino acids (pineal derived)
- Studied for
- Ageing; telomerase activation (claimed)
- UK status
- Not a licensed medicine; sold for research use
- Human evidence
- None published; cell and animal studies only
How it works
Telomeres are protective caps on the ends of chromosomes that shorten a little each time a cell divides. Telomerase is the enzyme that rebuilds them, and in most adult cells it is switched off. In a 2003 laboratory study on human cells, epithalon was reported to switch telomerase back on and lengthen telomeres. Animal work suggests wider effects on gene activity. The exact mechanism, and whether any of this matters in a living person, is not settled.
What the evidence shows
The evidence is mostly preclinical: cell cultures and animal studies, including one mouse study where average lifespan rose and tumours were less common. Mouse results do not carry straight across to people, and there are no published randomised human trials. So the ageing claims are interesting laboratory findings rather than proven human benefits.
What it does not settle
- There are no published human trials, and no established human dose.
- Long term safety in people is unknown.
- Because telomerase is also active in many cancers, switching it on is a theoretical risk that has not been studied in humans.
Side effects
Common
- Animal studies reported no significant toxicity over the animals' lifetimes.
- People who use it sometimes report injection site reactions, tiredness or vivid dreams, though these are not well documented.
Less common but serious
- The main theoretical concern is cancer, since telomerase supports the growth of many tumours. This has not been studied in people.
- Because there is no licensed product, the dose, purity and contents of material bought online cannot be verified.
Report any suspected side effect through the MHRA Yellow Card scheme.
UK legal status and access
Epithalon has no UK marketing authorisation, so it is not a licensed medicine and is not offered by registered clinics or pharmacies. It is sold online labelled for research use. A research label does not mean a product has been assessed for safety, quality or dose.
Common questions
What is epithalon?
A synthetic four amino acid peptide, based on a pineal gland substance, studied for ageing and known for a telomerase activating claim.
Does it extend life?
There are interesting animal results, but no human trials, so there is no proven effect on human lifespan or health.
Is it a licensed medicine in the UK?
No. It is sold only for research use and has no UK marketing authorisation.
The licensed route
There is no licensed epithalon. The best evidenced steps for healthy ageing remain sleep, activity, diet and not smoking. A registered clinician can advise.
Factual reference only, not medical advice. We give no dosing for unlicensed compounds.